Simultaneous folate intake may prevent adverse effect of valproic acid on neurulating nervous system

Ahmet Sukru Umur1, Mehmet Selcuki, Adem Bursali

  • 1Faculty of Medicine, Department of Neurosurgery, Celal Bayar University, Manisa, Turkey. umuras@yahoo.com

Insights

Folic acid (FA) effectively prevents valproic acid (VA)-induced neural tube defects in chick embryos. FA halts apoptosis, safeguarding early embryonic development from VA

Area of Science:

  • Developmental biology
  • Teratology
  • Neuroscience

Background:

  • Valproic acid (VA) is a known teratogen, associated with neural tube defects.
  • Folic acid (FA) is crucial for neural tube development.
  • Understanding the interplay between FA and VA in early embryogenesis is vital.

Purpose of the Study:

  • To investigate the preventive role of folic acid (FA) against valproic acid (VA)-induced teratogenicity.
  • To examine the effects on neural tube development in early-stage chick embryos.

Main Methods:

  • Chick embryos were divided into five groups: control, saline sham, VA-treated, FA-treated, and combined VA + FA treated.
  • Histological analyses, TUNEL assay for apoptosis, and immunoperoxidase techniques for specific proteins (p53, bcl-2, caspases) were employed.
  • Neural tube development and embryo viability were assessed after 72 hours.

Main Results:

  • VA exposure led to significant embryo mortality and developmental retardation.
  • Folic acid administration alone did not cause defects.
  • Simultaneous administration of VA and FA significantly reduced mortality and maldevelopmental delays compared to VA alone.

Conclusions:

  • Valproic acid (VA) appears to induce apoptosis, potentially independent of the p53 pathway.
  • Folic acid (FA) effectively mitigates VA's teratogenic effects during neurulation.
  • FA prevents VA-induced embryotoxicity by inhibiting the apoptotic cascade prior to caspase-3 activation.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...